CNS Pharmaceuticals, Inc. (CNSP) vs Moleculin Biotech, Inc. (MBRX)

• CNS Pharmaceuticals, Inc. CNSP 4.85 ▼ −6.37%
• Moleculin Biotech, Inc. MBRX 0.28 ▼ −24.32%

CNS Pharmaceuticals, Inc. and Moleculin Biotech, Inc. are both Biotechnology companies. CNS Pharmaceuticals, Inc. and Moleculin Biotech, Inc. are of similar size ($7.9M and $7.6M). CNS Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Across the 9 metrics below, CNS Pharmaceuticals, Inc. leads on 6 and Moleculin Biotech, Inc. on 3.